{"id":536057,"date":"2021-09-09T06:03:19","date_gmt":"2021-09-09T10:03:19","guid":{"rendered":"https:\/\/www.marketnewsdesk.com\/index.php\/new-research-on-sinovacs-covid-19-vaccine-shows-third-dose-more-effective-against-covid-19-including-the-delta-variant\/"},"modified":"2021-09-09T06:03:19","modified_gmt":"2021-09-09T10:03:19","slug":"new-research-on-sinovacs-covid-19-vaccine-shows-third-dose-more-effective-against-covid-19-including-the-delta-variant","status":"publish","type":"post","link":"https:\/\/www.marketnewsdesk.com\/index.php\/new-research-on-sinovacs-covid-19-vaccine-shows-third-dose-more-effective-against-covid-19-including-the-delta-variant\/","title":{"rendered":"New Research on SINOVAC\u2019s COVID-19 Vaccine Shows Third Dose More Effective Against COVID-19, Including the Delta Variant"},"content":{"rendered":"

<\/p>\n

\nNew Research on SINOVAC\u2019s COVID-19 Vaccine Shows Third Dose More Effective Against COVID-19, Including the Delta Variant\n<\/p>\n

Study findings demonstrate that a booster dose of inactivated COVID-19 vaccine produces a highly sifted, humoral immune response via a sustained evolution of antibodies, able to effectively neutralize SARS-CoV-2 variants of concern.<\/i><\/p>\n

BEIJING–(BUSINESS WIRE<\/a>)–
\nSINOVAC Biotech Ltd. (NASDAQ: SVA) (\u201cSinovac\u201d or the \u201cCompany\u201d), a leading provider of biopharmaceutical products in China, announced a paper, titled \u201cA third dose of inactivated vaccine augments the potency, breadth, and duration of anamnestic responses against SARS-CoV-2<\/a>,\u201d is available on medRxiv. The findings suggest a third dose of CoronaVac\u00ae can induce a better neutralization breadth to variants of concern (\u201cVOCs\u201d), including the Delta variant, a rapid immunological memory response, and a long-lasting humoral response. Having a third dose of inactivated COVID-19 vaccine is more effective for COVID-19 prevention.\n<\/p>\n

\nThis study includes an in-depth exploration of the immunogenic profiles of antibodies from three and two-dose CoronaVac\u00ae recipients and convalescents. The findings indicate that three-dose vaccinees demonstrated better neutralization breadth to VOCs, expeditious recall, and long-lasting humoral immune response. Analysis of 171 complex structures of neutralizing antibodies identified structure-activity correlation and revealed ultrapotent, VOCs-resistant, and broad-spectrum patches.\n<\/p>\n

\nAs part of this study, researchers also constructed immunogenic and mutational heat maps, which revealed a direct relationship between \u201chot\u201d immunogenic sites and areas with high mutation frequencies. Prolonged and repeated antigen stimulation can induce ongoing antibody somatic mutation, memory B cell clonal turnover, and antigen composition changes in B cell repertoire, which result in the development of monoclonal antibodies with enhanced neutralizing potency and breadth.\n<\/p>\n

\nThe above research provides a theoretical basis for a third dose of inactivated COVID-19 vaccine.\n<\/p>\n

About SINOVAC<\/b><\/p>\n

\nSINOVAC Biotech Ltd. is a China-based biopharmaceutical company that focuses on the research, development, manufacturing and commercialization of vaccines that protect against human infectious diseases. SINOVAC’s product portfolio includes vaccines against COVID-19, enterovirus71 (EV71), hepatitis A and B, seasonal influenza, 23-Valent pneumococcal polysaccharide (\u201cPPV\u201d), H5N1 pandemic influenza (avian flu), H1N1 influenza (swine flu), varicella, mumps and Poliomyelitis. SINOVAC\u2019s COVID-19 vaccine, CoronaVac\u00ae, has been granted emergency use approval or conditional marketing authorization by over 50 countries or regions worldwide. Healive\u00ae, the hepatitis A vaccine manufactured by the Company, has passed the assessment under WHO prequalification procedures in 2017. The EV71 vaccine, an innovative vaccine developed by SINOVAC against hand foot and mouth disease caused by EV71, was commercialized in China in 2016. In 2009, SINOVAC was the first company worldwide to receive approval for its H1N1 influenza vaccine, which it has supplied to the Chinese Government’s vaccination campaign and stockpiling program. The Company is also the only supplier of the H5N1 pandemic influenza vaccine to the government stockpiling program. In 2021, SINOVAC\u2019s Sabin-strain inactivated polio vaccine has approved for registration. The Company is developing several new products including combined vaccines. SINOVAC primarily sells its vaccines in China, while also exploring growth opportunities in international markets. The Company is seeking market authorization of its products in over 30 countries outside of China. For more information, please see the Company\u2019s website at www.sinovac.com<\/a>.\n<\/p>\n

Safe Harbor Statement<\/b><\/p>\n

\nThis press release may include certain statements that are not descriptions of historical facts, but are forward-looking statements. These statements are made under the \u201csafe harbor\u201d provisions of the U.S. Private Securities Litigation Reform Act of 1995. These forward-looking statements can be identified by terminology such as \u201cwill,\u201d \u201cexpects,\u201d \u201canticipates,\u201d \u201cfuture,\u201d \u201cintends,\u201d \u201cplans,\u201d \u201cbelieves,\u201d \u201cestimates\u201d and similar statements. Forward-looking statements involve risks, uncertainties and other factors that could cause actual results to differ materially from those contained in any such statements. In particular, the outcome of any litigation is uncertain, and the Company cannot predict the potential results of the litigation it filed or filed against it by others. Additionally, the triggering of a shareholder rights plan is nearly unprecedented, and the Company cannot predict the impact on the Company or its stock price as a result of the trigger of the rights plan.\n<\/p>\n

\"\"<\/p>\n

View source version on businesswire.com: <\/span>https:\/\/www.businesswire.com\/news\/home\/20210909005437\/en\/<\/a><\/span><\/p>\n

\nSinovac Biotech Ltd.
\n
Helen Yang
\n
Tel: +86-10-8279-9871 or
\n
+86-10-5693-1897
\n
Fax: +86-10-6296-6910
\n
Email: ir@sinovac.com<\/a><\/p>\n

\nICR Inc.
\n
Bill Zima
\n
U.S.: 1-646-308-1707
\n
Email: william.zima@icrinc.com<\/a><\/p>\n

KEYWORDS:<\/b> China Asia Pacific<\/p>\n

INDUSTRY KEYWORDS:<\/b> Science Other Science Biotechnology Research Pharmaceutical General Health Health Infectious Diseases<\/p>\n

MEDIA:<\/b><\/p>\n\n","protected":false},"excerpt":{"rendered":"

New Research on SINOVAC\u2019s COVID-19 Vaccine Shows Third Dose More Effective Against COVID-19, Including the Delta Variant Study findings demonstrate that a booster dose of inactivated COVID-19 vaccine produces a highly sifted, humoral immune response via a sustained evolution of antibodies, able to effectively neutralize SARS-CoV-2 variants of concern. BEIJING–(BUSINESS WIRE)– SINOVAC Biotech Ltd. (NASDAQ: SVA) (\u201cSinovac\u201d or the \u201cCompany\u201d), a leading provider of biopharmaceutical products in China, announced a paper, titled \u201cA third dose of inactivated vaccine augments the potency, breadth, and duration of anamnestic responses against SARS-CoV-2,\u201d is available on medRxiv. The findings suggest a third dose of CoronaVac\u00ae can induce a better neutralization breadth to variants of concern (\u201cVOCs\u201d), including the Delta variant, a rapid immunological memory … <\/p>\n

Continue reading “New Research on SINOVAC\u2019s COVID-19 Vaccine Shows Third Dose More Effective Against COVID-19, Including the Delta Variant”<\/span><\/a><\/p>\n","protected":false},"author":2,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[],"tags":[],"class_list":["post-536057","post","type-post","status-publish","format-standard","hentry"],"yoast_head":"\nNew Research on SINOVAC\u2019s COVID-19 Vaccine Shows Third Dose More Effective Against COVID-19, Including the Delta Variant - Market Newsdesk<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.marketnewsdesk.com\/index.php\/new-research-on-sinovacs-covid-19-vaccine-shows-third-dose-more-effective-against-covid-19-including-the-delta-variant\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"New Research on SINOVAC\u2019s COVID-19 Vaccine Shows Third Dose More Effective Against COVID-19, Including the Delta Variant - Market Newsdesk\" \/>\n<meta property=\"og:description\" content=\"New Research on SINOVAC\u2019s COVID-19 Vaccine Shows Third Dose More Effective Against COVID-19, Including the Delta Variant Study findings demonstrate that a booster dose of inactivated COVID-19 vaccine produces a highly sifted, humoral immune response via a sustained evolution of antibodies, able to effectively neutralize SARS-CoV-2 variants of concern. BEIJING–(BUSINESS WIRE)– SINOVAC Biotech Ltd. (NASDAQ: SVA) (\u201cSinovac\u201d or the \u201cCompany\u201d), a leading provider of biopharmaceutical products in China, announced a paper, titled \u201cA third dose of inactivated vaccine augments the potency, breadth, and duration of anamnestic responses against SARS-CoV-2,\u201d is available on medRxiv. The findings suggest a third dose of CoronaVac\u00ae can induce a better neutralization breadth to variants of concern (\u201cVOCs\u201d), including the Delta variant, a rapid immunological memory … Continue reading "New Research on SINOVAC\u2019s COVID-19 Vaccine Shows Third Dose More Effective Against COVID-19, Including the Delta Variant"\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.marketnewsdesk.com\/index.php\/new-research-on-sinovacs-covid-19-vaccine-shows-third-dose-more-effective-against-covid-19-including-the-delta-variant\/\" \/>\n<meta property=\"og:site_name\" content=\"Market Newsdesk\" \/>\n<meta property=\"article:published_time\" content=\"2021-09-09T10:03:19+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/cts.businesswire.com\/ct\/CT?id=bwnews&sty=20210909005437r1&sid=flmnd&distro=nx&lang=en\" \/>\n<meta name=\"author\" content=\"Newsdesk\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Newsdesk\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"4 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/new-research-on-sinovacs-covid-19-vaccine-shows-third-dose-more-effective-against-covid-19-including-the-delta-variant\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/new-research-on-sinovacs-covid-19-vaccine-shows-third-dose-more-effective-against-covid-19-including-the-delta-variant\\\/\"},\"author\":{\"name\":\"Newsdesk\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"headline\":\"New Research on SINOVAC\u2019s COVID-19 Vaccine Shows Third Dose More Effective Against COVID-19, Including the Delta Variant\",\"datePublished\":\"2021-09-09T10:03:19+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/new-research-on-sinovacs-covid-19-vaccine-shows-third-dose-more-effective-against-covid-19-including-the-delta-variant\\\/\"},\"wordCount\":746,\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/new-research-on-sinovacs-covid-19-vaccine-shows-third-dose-more-effective-against-covid-19-including-the-delta-variant\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/cts.businesswire.com\\\/ct\\\/CT?id=bwnews&sty=20210909005437r1&sid=flmnd&distro=nx&lang=en\",\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/new-research-on-sinovacs-covid-19-vaccine-shows-third-dose-more-effective-against-covid-19-including-the-delta-variant\\\/\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/new-research-on-sinovacs-covid-19-vaccine-shows-third-dose-more-effective-against-covid-19-including-the-delta-variant\\\/\",\"name\":\"New Research on SINOVAC\u2019s COVID-19 Vaccine Shows Third Dose More Effective Against COVID-19, Including the Delta Variant - Market Newsdesk\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/new-research-on-sinovacs-covid-19-vaccine-shows-third-dose-more-effective-against-covid-19-including-the-delta-variant\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/new-research-on-sinovacs-covid-19-vaccine-shows-third-dose-more-effective-against-covid-19-including-the-delta-variant\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/cts.businesswire.com\\\/ct\\\/CT?id=bwnews&sty=20210909005437r1&sid=flmnd&distro=nx&lang=en\",\"datePublished\":\"2021-09-09T10:03:19+00:00\",\"author\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"breadcrumb\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/new-research-on-sinovacs-covid-19-vaccine-shows-third-dose-more-effective-against-covid-19-including-the-delta-variant\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/new-research-on-sinovacs-covid-19-vaccine-shows-third-dose-more-effective-against-covid-19-including-the-delta-variant\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/new-research-on-sinovacs-covid-19-vaccine-shows-third-dose-more-effective-against-covid-19-including-the-delta-variant\\\/#primaryimage\",\"url\":\"https:\\\/\\\/cts.businesswire.com\\\/ct\\\/CT?id=bwnews&sty=20210909005437r1&sid=flmnd&distro=nx&lang=en\",\"contentUrl\":\"https:\\\/\\\/cts.businesswire.com\\\/ct\\\/CT?id=bwnews&sty=20210909005437r1&sid=flmnd&distro=nx&lang=en\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/new-research-on-sinovacs-covid-19-vaccine-shows-third-dose-more-effective-against-covid-19-including-the-delta-variant\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"New Research on SINOVAC\u2019s COVID-19 Vaccine Shows Third Dose More Effective Against COVID-19, Including the Delta Variant\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\",\"name\":\"Market Newsdesk\",\"description\":\"Latest Business News in Real Time\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\",\"name\":\"Newsdesk\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"caption\":\"Newsdesk\"},\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/author\\\/newsdesk\\\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"New Research on SINOVAC\u2019s COVID-19 Vaccine Shows Third Dose More Effective Against COVID-19, Including the Delta Variant - Market Newsdesk","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.marketnewsdesk.com\/index.php\/new-research-on-sinovacs-covid-19-vaccine-shows-third-dose-more-effective-against-covid-19-including-the-delta-variant\/","og_locale":"en_US","og_type":"article","og_title":"New Research on SINOVAC\u2019s COVID-19 Vaccine Shows Third Dose More Effective Against COVID-19, Including the Delta Variant - Market Newsdesk","og_description":"New Research on SINOVAC\u2019s COVID-19 Vaccine Shows Third Dose More Effective Against COVID-19, Including the Delta Variant Study findings demonstrate that a booster dose of inactivated COVID-19 vaccine produces a highly sifted, humoral immune response via a sustained evolution of antibodies, able to effectively neutralize SARS-CoV-2 variants of concern. BEIJING–(BUSINESS WIRE)– SINOVAC Biotech Ltd. (NASDAQ: SVA) (\u201cSinovac\u201d or the \u201cCompany\u201d), a leading provider of biopharmaceutical products in China, announced a paper, titled \u201cA third dose of inactivated vaccine augments the potency, breadth, and duration of anamnestic responses against SARS-CoV-2,\u201d is available on medRxiv. The findings suggest a third dose of CoronaVac\u00ae can induce a better neutralization breadth to variants of concern (\u201cVOCs\u201d), including the Delta variant, a rapid immunological memory … Continue reading \"New Research on SINOVAC\u2019s COVID-19 Vaccine Shows Third Dose More Effective Against COVID-19, Including the Delta Variant\"","og_url":"https:\/\/www.marketnewsdesk.com\/index.php\/new-research-on-sinovacs-covid-19-vaccine-shows-third-dose-more-effective-against-covid-19-including-the-delta-variant\/","og_site_name":"Market Newsdesk","article_published_time":"2021-09-09T10:03:19+00:00","og_image":[{"url":"https:\/\/cts.businesswire.com\/ct\/CT?id=bwnews&sty=20210909005437r1&sid=flmnd&distro=nx&lang=en","type":"","width":"","height":""}],"author":"Newsdesk","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Newsdesk","Est. reading time":"4 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/new-research-on-sinovacs-covid-19-vaccine-shows-third-dose-more-effective-against-covid-19-including-the-delta-variant\/#article","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/new-research-on-sinovacs-covid-19-vaccine-shows-third-dose-more-effective-against-covid-19-including-the-delta-variant\/"},"author":{"name":"Newsdesk","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"headline":"New Research on SINOVAC\u2019s COVID-19 Vaccine Shows Third Dose More Effective Against COVID-19, Including the Delta Variant","datePublished":"2021-09-09T10:03:19+00:00","mainEntityOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/new-research-on-sinovacs-covid-19-vaccine-shows-third-dose-more-effective-against-covid-19-including-the-delta-variant\/"},"wordCount":746,"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/new-research-on-sinovacs-covid-19-vaccine-shows-third-dose-more-effective-against-covid-19-including-the-delta-variant\/#primaryimage"},"thumbnailUrl":"https:\/\/cts.businesswire.com\/ct\/CT?id=bwnews&sty=20210909005437r1&sid=flmnd&distro=nx&lang=en","inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/new-research-on-sinovacs-covid-19-vaccine-shows-third-dose-more-effective-against-covid-19-including-the-delta-variant\/","url":"https:\/\/www.marketnewsdesk.com\/index.php\/new-research-on-sinovacs-covid-19-vaccine-shows-third-dose-more-effective-against-covid-19-including-the-delta-variant\/","name":"New Research on SINOVAC\u2019s COVID-19 Vaccine Shows Third Dose More Effective Against COVID-19, Including the Delta Variant - Market Newsdesk","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/#website"},"primaryImageOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/new-research-on-sinovacs-covid-19-vaccine-shows-third-dose-more-effective-against-covid-19-including-the-delta-variant\/#primaryimage"},"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/new-research-on-sinovacs-covid-19-vaccine-shows-third-dose-more-effective-against-covid-19-including-the-delta-variant\/#primaryimage"},"thumbnailUrl":"https:\/\/cts.businesswire.com\/ct\/CT?id=bwnews&sty=20210909005437r1&sid=flmnd&distro=nx&lang=en","datePublished":"2021-09-09T10:03:19+00:00","author":{"@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"breadcrumb":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/new-research-on-sinovacs-covid-19-vaccine-shows-third-dose-more-effective-against-covid-19-including-the-delta-variant\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.marketnewsdesk.com\/index.php\/new-research-on-sinovacs-covid-19-vaccine-shows-third-dose-more-effective-against-covid-19-including-the-delta-variant\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/new-research-on-sinovacs-covid-19-vaccine-shows-third-dose-more-effective-against-covid-19-including-the-delta-variant\/#primaryimage","url":"https:\/\/cts.businesswire.com\/ct\/CT?id=bwnews&sty=20210909005437r1&sid=flmnd&distro=nx&lang=en","contentUrl":"https:\/\/cts.businesswire.com\/ct\/CT?id=bwnews&sty=20210909005437r1&sid=flmnd&distro=nx&lang=en"},{"@type":"BreadcrumbList","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/new-research-on-sinovacs-covid-19-vaccine-shows-third-dose-more-effective-against-covid-19-including-the-delta-variant\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.marketnewsdesk.com\/"},{"@type":"ListItem","position":2,"name":"New Research on SINOVAC\u2019s COVID-19 Vaccine Shows Third Dose More Effective Against COVID-19, Including the Delta Variant"}]},{"@type":"WebSite","@id":"https:\/\/www.marketnewsdesk.com\/#website","url":"https:\/\/www.marketnewsdesk.com\/","name":"Market Newsdesk","description":"Latest Business News in Real Time","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.marketnewsdesk.com\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Person","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979","name":"Newsdesk","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","caption":"Newsdesk"},"url":"https:\/\/www.marketnewsdesk.com\/index.php\/author\/newsdesk\/"}]}},"_links":{"self":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/536057","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/comments?post=536057"}],"version-history":[{"count":0,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/536057\/revisions"}],"wp:attachment":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/media?parent=536057"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/categories?post=536057"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/tags?post=536057"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}